Nataliya Agafonova - 24 Jul 2023 Form 4 Insider Report for Longeveron Inc. (LGVN)

Role
Chief Medical Officer
Signature
/s/ Paul Lehr, attorney-in-fact
Issuer symbol
LGVN
Transactions as of
24 Jul 2023
Net transactions value
$0
Form type
4
Filing time
02 Aug 2023, 17:00:13 UTC
Previous filing
13 Jul 2023
Next filing
22 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGVN Common Stock Award $0 +30,000 $0.000000 30,000 24 Jul 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the award of 30,000 Restricted Stock Units, which vest 25% on each of the award date, October 1, 2023, January 1, 2024, and April 1, 2024.
F2 Includes 22,500 Restricted Stock Units.